BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7.
With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process.
To view the multimedia release go to:
https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
Medical transcription companies are the unseen engine of healthcare. Every dictation, every observation, every detail must be captured and transformed into records that clinicians can trust. At MTS, we don’t just transcribe — we translate spoken care into actionable documentation.
Our transcription services deliver speed without sacrificing accuracy, HIPAA-compliant safeguards that protect every file, and seamless EMR integration that keeps workflows moving. With specialty-trained transcriptionists, practices gain records that support decisions, patients receive care without delay, and providers work with confidence.
In medicine, transcription isn’t background work — it’s the pulse of clinical precision.
